Drug associations as alternative and complementary therapy for neglected tropical diseases

LRM Ferraz, LCPBB Silva, ML de Souza, LP Alves… - Acta Tropica, 2022 - Elsevier
The present paper aims to establish different treatments for neglected tropical disease by a
survey on drug conjugations and possible fixed-dose combinations (FDC) used to obtain …

Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis

C Liu, D Fisher, K Pronyuk, E Musabaev… - Frontiers in …, 2024 - frontiersin.org
Schistosomiasis is a parasitic disease that endangers human health and social
development. The granulomatous reaction of Schistosoma eggs in the liver is the main …

[HTML][HTML] Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni

MM Eissa, MZ El-Azzouni, LK El-Khordagui… - Parasites & vectors, 2020 - Springer
Background The control of schistosomiasis has been centered to date on a single drug,
praziquantel, with shortcomings including treatment failure, reinfection, and emergence of …

[HTML][HTML] Oral administration of artemisone for the treatment of schistosomiasis: Formulation challenges and in vivo efficacy

J Zech, D Gold, N Salaymeh, NC Sasson… - Pharmaceutics, 2020 - mdpi.com
Artemisone is an innovative artemisinin derivative with applications in the treatment of
malaria, schistosomiasis and other diseases. However, its low aqueous solubility and …

Synthetic Aurones: New Features for Schistosoma mansoni Therapy

D Silva Torres, B Alves de Oliveira… - Chemistry & …, 2021 - Wiley Online Library
In this work, two synthetic aurones revealed moderate schistosomicidal potential in in vitro
and in vivo assays. Aurones (1) and (2) promoted changes in tegument integrity and motor …

Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni

OS Mohammad, HM Hussein, SW Abdel-Sayed… - Parasitology …, 2024 - Springer
Schistosomiasis is a neglected tropical disease associated with considerable morbidity.
Praziquantel (PZQ) is effective against adult schistosomes, yet, it has little effect on juvenile …

Dealing with schistosomiasis: Current drug discovery strategies

S Gemma, S Federico, S Brogi, M Brindisi… - Annual Reports in …, 2019 - Elsevier
Schistosomiasis is one of the most prevalent parasitic diseases, accounting for heavy
socioeconomical and health burden in endemic countries. The control of this neglected …

Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice

ANA Sabra, MB Salem, S William, OA Hammam… - Experimental …, 2022 - Elsevier
Abstract Treatment of schistosomiasis is heavily reliant on the single antischistosomal drug
praziquantel (PZQ). The use of synergistic drug-drug interactions is one possible solution …

[HTML][HTML] Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo

ZY Yang, ZH Liu, YN Zhang, C Li, L Liu, WJ Pu… - Parasites & vectors, 2021 - Springer
Background Schistosomiasis is a debilitating and neglected tropical disease for which
praziquantel (PZQ) remains the first-choice drug for treatment and control of the disease. In …

Paeoniflorin in experimental BALB/c mansoniasis: a novel anti-angiogenic therapy

NF Abd El-Aal, EH Abdelbary - Experimental parasitology, 2019 - Elsevier
Chronic hepatic schistosomiasis causes portal hypertension, fibrosis and lethal
hepatosplenic complications. Previous studies focused mainly on schistosomicidal drugs …